Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial. - Khouri IF; Alzahrani K; Kantarjian H; Milton DR; Gulbis AM; Sasaki K; Jain N; Short NJ; Kadia T; Daher M; Rafei H; Im JS; et al. (American journal of hematology, 2024)